Aripiprazole-Associated Acute Dystonia During Dose Reduction in Patient With Schizophrenia and Dementia: A Case Report

J Clin Psychopharmacol. 2022 Sep-Oct;42(5):508-509. doi: 10.1097/JCP.0000000000001581. Epub 2022 Jul 4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Aripiprazole / adverse effects
  • Dementia* / drug therapy
  • Drug Tapering
  • Dystonia* / chemically induced
  • Dystonic Disorders* / drug therapy
  • Humans
  • Schizophrenia* / drug therapy

Substances

  • Antipsychotic Agents
  • Aripiprazole